ELI LILLY AND COMPANY | Advisory Shareholder Votes for Certain Directors at ELI LILLY AND COMPANY

Status
Omitted
Previous AGM date
Resolution details
Company ticker
LLY
Lead filer
Resolution ask
Adopt or amend a policy
ESG theme
  • Governance
ESG sub-theme
  • Shareholder rights
Type of vote
Shareholder proposal
Filer type
Shareholder
Company sector
Health Care
Company HQ country
United States
Resolved clause
RESOLVED, shareholders ask that Eli Lilly arrange for an advisory vote on each director who does not stand for election in a given year. This proposal is necessary because Eli Lilly directors have 3-year terms which makes directors far less accountable. It is highly unlikely that this will change because the Lilly Endowment is opposed to annual election of each director and has enough voting power to prevent annual election of each director. Advisory votes for certain directors is similar to the advisory vote on executive pay that LLY conducts. When LLY initiated advisory votes on executive pay it did not need to change the bylaws because the votes were advisory. This proposal will focus LLY shareholders on the performance and qualifications of each LLY director each year so that LLY shareholders will be better prepared to cast informed votes when directors are up for a binding shareholder vote after 3-years

DISCLAIMER: By including a shareholder resolution or management proposal in this database, neither the PRI nor the sponsor of the resolution or proposal is seeking authority to act as proxy for any shareholder; shareholders should vote their proxies in accordance with their own policies and requirements.

Any voting recommendations set forth in the descriptions of the resolutions and management proposals included in this database are made by the sponsors of those resolutions and proposals, and do not represent the views of the PRI.

Information on the shareholder resolutions, management proposals and votes in this database have been obtained from sources that are believed to be reliable, but the PRI does not represent that it is accurate, complete, or up-to-date, including information relating to resolutions and management proposals, other signatories’ vote pre-declarations (including voting rationales), or the current status of a resolution or proposal. You should consult companies’ proxy statements for complete information on all matters to be voted on at a meeting.